glp-1 obesity drug news updates The next phase of the race New weight-loss drugs surge in
Description
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
Explore the pros and cons of GLP-1 medications for managing type 2 diabetes and weight loss.
Why the first non-peptide oral GLP-1 is drawing serious attentionand where caution still applies
